|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 11 2619-2625, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
SJ Campbell, F Carlotti, PA Hall, AJ Clark and CR Wolf
University of Dundee, Biomedical Research Centre, Ninewells Hospital and Medical School, UK.
Mammalian cytochrome P-450s in the CYP1A gene family catalyse the oxidation of a wide range of drugs and foreign compounds resulting in their excretion. These enzymes are highly inducible by a range of compounds, including polycyclic aromatic hydrocarbons such as 3-methylcholanthrene (3-MC) and dioxins. Analysis of the CYP1A1 promoter has identified dioxin responsive enhancer elements which mediate the induction response. In order to evaluate this promoter as an in vivo regulatable expression system and to gain further insights into the tissue specific regulation of this gene, an 8.5 kb genomic fragment of the rat CYP1A1 promoter was cloned upstream of the lacZ reporter gene. This construct was used to generate transgenic mice and three independent lines were expanded for further study. The regulation of beta-galactosidase expression was determined in mock and 3-MC-treated mice in an extensive range of tissues. In untreated animals no transgene expression was detectable over non-transgenic controls. Treatment with 3-MC caused a profound increase in transgene expression (> 1,000-fold) in many tissues including liver, adrenal, kidney and intestine. Inducible transgene expression was also detectable in many of the other tissues including the spleen, lung, pancreas and the reproductive organs. Although the absolute levels of induction varied, no significant differences in the pattern of transgene expression were observed between the three different transgenic mouse lines. In addition, the pattern of transgene expression correlated closely with the reported regulation of CYP1A1 protein. These results indicate that the CYP1A1 promoter can drive expression of heterologous genes in a truly on/off manner in a variety of tissues and cell types which will allow the expression of other proteins to be controlled in vivo. This reporter system also provides a model for establishing the environmental and hormonal factors regulating the expression of the CYP1A1 gene.
This article has been cited by other articles:
![]() |
R. M. Ortiz, M. L. Graciano, J. J. Mullins, and K. D. Mitchell Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1584 - F1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Finn, A. W. McLaren, D. Carrie, C. J. Henderson, and C. R. Wolf Conditional Deletion of Cytochrome P450 Oxidoreductase in the Liver and Gastrointestinal Tract: A New Model for Studying the Functions of the P450 System J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 40 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Graciano, C. R. Mouton, M. E. Patterson, D. M. Seth, J. J. Mullins, and K. D. Mitchell Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1858 - F1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Operana, N. Nguyen, S. Chen, D. Beaton, and R. H. Tukey Human CYP1A1GFP Expression in Transgenic Mice Serves as a Biomarker for Environmental Toxicant Exposure Toxicol. Sci., January 1, 2007; 95(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Opay, C. R. Mouton, J. J. Mullins, and K. D. Mitchell Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, September 1, 2006; 291(3): F612 - F618. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D Mitchell, S. J Bagatell, C. S Miller, C. R Mouton, D. M Seth, and J. J Mullins Genetic Clamping of Renin Gene Expression Induces Hypertension and Elevation of Intrarenal Ang II Levels of Graded Severity in Cyp1a1-Ren2 Transgenic Rats Journal of Renin-Angiotensin-Aldosterone System, June 1, 2006; 7(2): 74 - 86. [Abstract] [PDF] |
||||
![]() |
K. D. Mitchell and J. J. Mullins Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1210 - F1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Patterson, C. R. Mouton, J. J. Mullins, and K. D. Mitchell Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension Am J Physiol Renal Physiol, October 1, 2005; 289(4): F754 - F759. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Howard, M. E. Patterson, J. J. Mullins, and K. D. Mitchell Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats Am J Physiol Renal Physiol, April 1, 2005; 288(4): F810 - F815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Campbell, C. J. Henderson, D. C. Anthony, D. Davidson, A. J. Clark, and C. R. Wolf The Murine Cyp1a1 Gene Is Expressed in a Restricted Spatial and Temporal Pattern during Embryonic Development J. Biol. Chem., February 18, 2005; 280(7): 5828 - 5835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Galijatovic, D. Beaton, N. Nguyen, S. Chen, J. Bonzo, R. Johnson, S. Maeda, M. Karin, F. P. Guengerich, and R. H. Tukey The Human CYP1A1 Gene Is Regulated in a Developmental and Tissue-specific Fashion in Transgenic Mice J. Biol. Chem., June 4, 2004; 279(23): 23969 - 23976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Henderson and C. R. Wolf Transgenic Analysis of Human Drug-Metabolizing Enzymes: Preclinical Drug Development and Toxicology Mol. Interv., September 1, 2003; 3(6): 331 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bockamp, M. Maringer, C. Spangenberg, S. Fees, S. Fraser, L. Eshkind, F. Oesch, and B. Zabel Of mice and models: improved animal models for biomedical research Physiol Genomics, December 3, 2002; 11(3): 115 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gradin, R. Toftgard, L. Poellinger, and A. Berghard Repression of Dioxin Signal Transduction in Fibroblasts. IDENTIFICATION OF A PUTATIVE REPRESSOR ASSOCIATED WITH Arnt J. Biol. Chem., May 7, 1999; 274(19): 13511 - 13518. [Abstract] [Full Text] [PDF] |
||||